We are live on ! Find out more
LABD icon

Direxion Daily S&P Biotech Bear 3X ETF

18 hedge funds and large institutions have $30.9M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 1

125% more funds holding

Funds holding: 818 (+10)

51% more capital invested

Capital invested by funds: $20.5M → $30.9M (+$10.4M)

0.02% less ownership

Funds ownership: 0.19%0.17% (-0.02%)

25% less call options, than puts

Call options by funds: $1.89M | Put options by funds: $2.53M

Holders
18
Holders Change
+10
Holders Change %
+125%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
6
Reduced
Closed
1
Calls
$1.89M
Puts
$2.53M
Net Calls
-$639K
Net Calls Change
-$2.45M

LABD Hedge Fund Activity: Q2 2020 in Review

18 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q2 2020, worth a combined $30.9M — up 51% from $20.5M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new LABD positions and 1 closed out — a net gain of 10 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Boxer Capital, adding an estimated $36.1M. The largest seller was First Light Asset Management, exiting entirely with an estimated $217K sold.

  • 18 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q2 2020, up from 8 in Q1 2020.
  • Funds reported $30.9M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q2 2020, up 51% quarter-over-quarter.
  • 11 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q2 2020 and 1 closed out, a net change of +10 holders.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q2 2020 was Boxer Capital, an estimated $36.1M added.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q2 2020 was First Light Asset Management, an estimated $217K sold.

Based on aggregated 13F filings for Q2 2020.